Graeme Wald
Plus aucun poste en cours
Profil
Graeme Wald served as an Independent Non-Executive Director at Nexvet Biopharma Plc from 2013 to 2015.
He also worked as a Director at Nexvet Australia Pty Ltd.
and as a Research Analyst at Pinnacle Investment Management Group Ltd.
Wald was a Principal at OneVentures Management Pty Ltd.
Additionally, he worked as a Fund Manager at Fedsure Asset Management Co. (Pty) Ltd.
from 1999 to 2001.
Wald earned his undergraduate, MBA, and doctorate degrees from the University of the Witwatersrand.
Anciens postes connus de Graeme Wald
| Sociétés | Poste | Fin |
|---|---|---|
| NEXVET BIOPHARMA PUBLIC LIMITED CO | Directeur/Membre du Conseil | 30/06/2015 |
Fedsure Asset Management Co. (Pty) Ltd.
 Fedsure Asset Management Co. (Pty) Ltd. Investment ManagersFinance Fedsure Asset Management Co. (Pty) Ltd. provides asset management services. The private company is based in Johannesburg, South Africa. | Corporate Officer/Principal | 01/05/2001 |
OneVentures Management Pty Ltd.
 OneVentures Management Pty Ltd. Investment ManagersFinance OneVentures Management Pty Ltd. (OneVentures) is a venture capital firm, a susbidiary of Andover Group Pty Ltd was founded in 2006 by Dr Michelle Deaker. The firm is headquartered in Australia. | Private Equity Investor | - |
Nexvet Australia Pty Ltd.
 Nexvet Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Nexvet Australia Pty Ltd. operates as a global clinical-stage biopharmaceutical company that develops and distributes medicines for companion animals. The firm focuses on transforming the therapeutic market by developing and commercializing novel biologic therapies, including products derived from its PETization technology. PETization is designed to rapidly create monoclonal antibodies that are recognized as “self” by a patient’s immune system. The company was founded by Mark Heffernan, Christopher Nigel Brown and David Gearing in February 2010 and is headquartered in Melbourne, Australia. | Directeur/Membre du Conseil | - |
| Pinnacle Investment Management Group Ltd. (Broker) | Analyst-Equity | - |
Formation de Graeme Wald
| University of the Witwatersrand | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Nexvet Biopharma Plc
 Nexvet Biopharma Plc Pharmaceuticals: MajorHealth Technology Nexvet Biopharma Plc engaged in the provision of integrated biopharmaceutical business. It focused on transforming the therapeutic market for companion animals, such as dogs and cats, by developing and commercializing novel, species-specific biologics. The company was founded in September 2014 and was headquartered in Dublin, Ireland. | Health Technology |
| Pinnacle Investment Management Group Ltd. (Broker) | Finance |
OneVentures Management Pty Ltd.
OneVentures Management Pty Ltd. Investment ManagersFinance OneVentures Management Pty Ltd. (OneVentures) is a venture capital firm, a susbidiary of Andover Group Pty Ltd was founded in 2006 by Dr Michelle Deaker. The firm is headquartered in Australia. | Finance |
Nexvet Australia Pty Ltd.
Nexvet Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Nexvet Australia Pty Ltd. operates as a global clinical-stage biopharmaceutical company that develops and distributes medicines for companion animals. The firm focuses on transforming the therapeutic market by developing and commercializing novel biologic therapies, including products derived from its PETization technology. PETization is designed to rapidly create monoclonal antibodies that are recognized as “self” by a patient’s immune system. The company was founded by Mark Heffernan, Christopher Nigel Brown and David Gearing in February 2010 and is headquartered in Melbourne, Australia. | Health Technology |
Fedsure Asset Management Co. (Pty) Ltd.
Fedsure Asset Management Co. (Pty) Ltd. Investment ManagersFinance Fedsure Asset Management Co. (Pty) Ltd. provides asset management services. The private company is based in Johannesburg, South Africa. | Finance |
